Literature DB >> 9892200

CMAP: a novel cystatin-like gene involved in liver metastasis.

M Morita1, N Yoshiuchi, H Arakawa, S Nishimura.   

Abstract

A novel metastasis-associated gene was identified with a differential display system in murine carcinoma cells showing a high rate of metastasis to the liver. A human homologue was also identified using a PCR-based strategy. The protein coded by this gene was named cystatin-like metastasis-associated protein (CMAP) and showed 22.1-28.1% homology to human family 2 cystatins. CMAP mRNA was selectively overexpressed in all murine liver metastatic tumors but not in any pulmonary metastatic tumors examined. Transfection of CMAP antisense DNA into highly metastatic liver cells greatly decreased their metastatic potential and CMAP expression, indicating that CMAP is involved in liver metastatic ability after intravasation of malignant cells. The human homologue of CMAP was found to be expressed in various human cancer cell lines established from malignant tumors. Our discovery of this novel liver metastasis-related gene indicates a new approach to the diagnosis and/or prevention of liver metastasis of human cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892200

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Proteinases and their inhibitors in liver cancer.

Authors:  Verena Puxbaum; Lukas Mach
Journal:  World J Hepatol       Date:  2009-10-31

2.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Authors:  Sanjeev K Baniwal; Omar Khalid; Yankel Gabet; Ruchir R Shah; Daniel J Purcell; Deepak Mav; Alice E Kohn-Gabet; Yunfan Shi; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

3.  Cystatin F Ensures Eosinophil Survival by Regulating Granule Biogenesis.

Authors:  Stephen P Matthews; Sarah J McMillan; Jeff D Colbert; Rachel A Lawrence; Colin Watts
Journal:  Immunity       Date:  2016-04-05       Impact factor: 31.745

4.  Cystatin F Affects Natural Killer Cell Cytotoxicity.

Authors:  Milica Perišić Nanut; Jerica Sabotič; Urban Švajger; Anahid Jewett; Janko Kos
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

5.  Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction.

Authors:  Serena Zacchigna; Valentina Martinelli; Silvia Moimas; Andrea Colliva; Marco Anzini; Andrea Nordio; Alessia Costa; Michael Rehman; Simone Vodret; Cristina Pierro; Giulia Colussi; Lorena Zentilin; Maria Ines Gutierrez; Ellen Dirkx; Carlin Long; Gianfranco Sinagra; David Klatzmann; Mauro Giacca
Journal:  Nat Commun       Date:  2018-06-26       Impact factor: 14.919

6.  Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer.

Authors:  Zhang Yan; Yin Lijuan; Wu Yinhang; Jin Yin; Xu Jiamin; Wu Wei; Pan Yuefen; Han Shuwen
Journal:  World J Surg Oncol       Date:  2022-01-04       Impact factor: 2.754

Review 7.  Lysosomes and lysosome-related organelles in immune responses.

Authors:  Colin Watts
Journal:  FEBS Open Bio       Date:  2022-03-29       Impact factor: 2.792

8.  Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma.

Authors:  You-Fang Chen; Gang Ma; Xun Cao; Rong-Zhen Luo; Li-Ru He; Jie-Hua He; Zhi-Liang Huang; Mu-Sheng Zeng; Zhe-Sheng Wen
Journal:  BMC Surg       Date:  2013-05-28       Impact factor: 2.102

9.  Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis.

Authors:  Garth Hamilton; Jeff D Colbert; Alexander W Schuettelkopf; Colin Watts
Journal:  EMBO J       Date:  2008-02-06       Impact factor: 11.598

10.  Regulation of split anergy in natural killer cells by inhibition of cathepsins C and H and cystatin F.

Authors:  Špela Magister; Han-Ching Tseng; Vickie T Bui; Janko Kos; Anahid Jewett
Journal:  Oncotarget       Date:  2015-09-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.